About NetraMark
NetraMark is a company based in Toronto (Canada) founded in 2015 was acquired by Nurosene in October 2021. It operates as a AI-as-a-Service. NetraMark offers products and services including NetraAI. NetraMark operates in a competitive market with competitors including Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Netramark Holdings Inc
-
Annual Revenue
$310.66 K (USD)-5.18as on Sep 30, 2025
-
Net Profit
$-3.75 M (USD)-56.72as on Sep 30, 2025
-
EBITDA
$-3.78 M (USD)-51.6as on Sep 30, 2025
-
Latest Funding Round
$2.24 M (USD), Post-IPO
Jan 13, 2026
-
Investors
Nurosene
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Nurosene
(Oct 12, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NetraMark
NetraMark is a publicly listed company on the CSE with ticker symbol AIAI in Canada, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NetraMark
NetraMark offers a comprehensive portfolio of products and services, including NetraAI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool used for clinical trial optimization insights.
Unlock access to complete
Funding Insights of NetraMark
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $2.2M
-
First Round
First Round
(21 Jun 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Post-IPO - NetraMark | Valuation |
investors |
|
| Dec, 2025 | Amount | Grant - NetraMark | Valuation |
investors |
|
| Sep, 2023 | Amount | Post-IPO - NetraMark | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NetraMark
NetraMark has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Nurosene and Ontario Brain Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brain research and care innovation is driven in Ontario.
|
Founded Year | Domain | Location | |
|
Psychological health exercises are delivered via a mobile application.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NetraMark
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NetraMark
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Netramark Comparisons
Competitors of NetraMark
NetraMark operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI-driven drug discovery platform for the treatment of cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Netramark
Frequently Asked Questions about NetraMark
When was NetraMark founded?
NetraMark was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is NetraMark located?
NetraMark is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
What is the annual revenue of NetraMark?
Annual revenue of NetraMark is $310.66K as on Sep 30, 2025.
What does NetraMark do?
NetraMark is engaged in providing AI-driven solutions to optimize clinical trial designs. The company operates in the healthcare and technology sectors, offering innovative tools like NetraAI, powered by proprietary Attractor AI algorithms. Insights into patient correlations, treatment efficacy, toxicity, and placebo responses are generated. Trial risks are reduced through enhanced patient stratification and smarter protocol design. The focus is placed on improving decision-making for clinical development teams across various disease areas.
Who are the top competitors of NetraMark?
NetraMark's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does NetraMark offer?
NetraMark offers NetraAI.
Is NetraMark publicly traded?
Yes, NetraMark is publicly traded on CSE under the ticker symbol AIAI.
Who are NetraMark's investors?
NetraMark has 2 investors. Key investors include Nurosene, and Ontario Brain Institute.
What is NetraMark's ticker symbol?
The ticker symbol of NetraMark is AIAI on CSE.